A. House

Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada.

M. Tunis, C. Quach, A. Killikelly, 2020, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Epidemiology of Clostridioides difficile infection in Canada: A six-year review to support vaccine decision-making.

C. Quach, C. Frenette, K. Katz, 2019, Canada communicable disease report = Releve des maladies transmissibles au Canada.

What is new in the Canadian Immunization Guide: November 2016 to November 2018.

M. Tunis, A. House, A. Fleurant-Ceelen, 2018, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Demonstrating the capacity of the National Advisory Committee on Immunization for timely responses to post-market vaccine monitoring signals: Canada's experience with the live-attenuated influenza vaccine.

M. Tunis, K. Young, R. Stirling, 2021, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Gap analyses to assess Canadian readiness for respiratory syncytial virus vaccines: Report from an expert retreat.

M. Tunis, C. Bancej, C. Quach, 2020, Canada communicable disease report = Releve des maladies transmissibles au Canada.

Guidelines for the Economic Evaluation of Vaccination Programs in Canada

A. House, Mark Jit, Murray Krahn, 2023, SSRN Electronic Journal.